Company intelligence / Profile preview

Cookies

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Cookies is a global cannabis brand recognized for developing proprietary cannabis cultivars, with over 70 strains, and offering more than 2,000 products worldwide. The company is best known for its genetically engineered cannabis plants and its impact on cannabis culture, but not for drug development in the pharmaceutical or biotech sense. No clinical trial data for pharmaceutical drug candidates are reported, nor does the company appear to be developing treatments beyond plant-based cannabis products for recreational and medical use[1][4][9].

Therapeutic areas: PsychiatryImmunologyNeurology
Modalities: Plant-based medication
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Cookies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cookies.

Explore the full profile